bilaterals.org logo
bilaterals.org logo

intellectual property

Live from the TPP: IP chapter shows no sign of resolution, end of negotiation in 2013 highly unlikely
21-May-2013 Infojustice
There is a strong sense in the halls of the current TPP negotiation that the end is not in sight. And one of the primary reasons s a lack of consensus on intellectual property and pharmaceuticals issues, reports Infojustice from Lima.
IPR lists for trans-Atlantic trade deal still growing; Risk of locking in old IPR regimes?
16-May-2013 IP Watch
Locking in Europe and the United States to “old” intellectual property regimes is the one “killer argument” against including an IP chapter in the upcoming Transatlantic Trade and Investment Partnership (TTIP), according to Bernd Hugenholtz, director of the Institute for Information Law (IViR) at the University of Brussels.
Copyright and secrecy don’t make for good trade agreements
14-May-2013 Infojustice
Copyright is an uncomfortable fit for a trade agreement and should be kept out of the United States-European Union Free Trade Agreement.
Investors’ IP rights unbound: The danger of investment clauses to access to medicines
25-Apr-2013 Infojustice
Although access to medicines activists have been wise to focus our attention intently on convincing low- and middle-income countries to adopt and use all possible TRIPS-compliant flexibilities and to oppose the TRIPS-plus IP chapters in free trade agreements, we have neglected to interrogate another chapter in free trade agreements and bilateral investment treaties that perhaps pose an even greater threat to our collective access to medicines – investment chapters.
No changing intellectual property laws: Sharma
18-Apr-2013 Hindu Business Line
India wíll not tighten laws on intellectual property or go beyond the global intellectual property agreement, TRIPS, in the free trade agreement (FTA) being negotiated with the European Union.
India-EU FTA won’t hit generic drugs industry: EU envoy
13-Apr-2013
The much-hyped bilateral trade and investment agreement (BTIA) between India and the European Union (EU) would not impact the Indian generic drugs industry or lead to a change in the country’s patent law, João Cravinho, EU ambassador to India, said on Friday.
Join the rally to oppose EU-India FTA!
9-Apr-2013
Around 2000 people including people living with HIV (PLHIV), patient groups and public health activists will take to the streets and rally from Barakhamba road to Jantar Mantar at 11.00 am on 10 April 2013 to voice concerns and protest against harmful provisions being pushed by the EU-India FTA negotiations
Manmohan Singh must learn from the Novartis judgement
2-Apr-2013 First Post
Will Manmohan Singh understand the clear purpose behind the national sentiment around the Supreme Court judgment on Novartis’ cancer drug Glivec? If he does, he should take a relook at the India-EU Free Trade Agreement that is cooking in his back-room.
European Union sets tough conditions under FTA
1-Apr-2013 LiveMint
The gains accruing to the Indian generic drugs industry as a result of the Supreme Court judgement on the Novartis case may be lost if India accepts demands by the European Union (EU) under the proposed free trade agreement (FTA) between the two sides.
EU-India FTA - IP chapter text (draft, date unknown)
29-Mar-2013 KEI
Negotiating text on intellectual property for the EU-India FTA. It does not include Article 6 (patents) or have any text for Article 9 (GIs). Date unknown.
Indian pharma sector fears India-European Union FTA could imperil local industry
27-Mar-2013
Drugmakers and healthcare activists are worried that the India-European Union Free Trade Agreement (FTA), which is in the works, may contain a provision that could imperil local industry and have urged the government to keep patent infringement issues out of FTAs.
Government moves to protect rooibos in EU — eight years on
27-Mar-2013 Business Day
A French company’s attempt to claim "rooibos" as its own intellectual property has galvanised the South African government into action to protect the term under its talks with Brussels over the EU-South Africa EPA.
Amul requests for a relook at EU-India FTA
27-Mar-2013 Times of India
India’s largest dairy co-operative - Amul - has requested the commerce ministry to relook at the EU-India Free Trade Agreement.
EU FTA, TRIPS plus could hit Indian generic drug makers
25-Mar-2013 Live Mint
The FTA might enable seizure of property of generic drug makers on suspicion of IP rights infringement
Differences in prominent US and EU treaties concerning liability for service providers
22-Mar-2013 Infojustice
A comparison of language between two of the most substantive and recent free trade agreements (FTAs) adopted by the US and the EU for one controversial area of IP: liability for internet service providers (ISP) for infringing content.
European Union-India FTA may hit generic medical industry
21-Mar-2013
The free trade agreement that European Union is pushing India to sign could put an end to India’s status as the pharmacy of the developing providing affordable medicines, especially HIV drugs to countries like Brazil, Thailand, South Africa, Zimbabwe and several others. The negotiations with EU are on at a feverish pace this week in Brussels even before the parliamentary standing committee looking into the free trade agreements (FTAs) has submitted its report.
Civil society statement – No copyright in the EU-US trade agreement!
19-Mar-2013 Infojustice
"From a democratic perspective, we believe that important rules governing technology, health, and culture should be debated in the US Congress, the European Parliament, national parliaments, and other transparent forums where all stakeholders can be heard—not in closed negotiations that give privileged access to corporate insiders."
Trans-Pacific Partnership Agreement: an interview with Judit Rius, Médecins Sans Frontières
12-Mar-2013 New Medical
The TPP negotiators are making decisions that will affect at least 600 million people, and potentially hundreds of millions more, in complete secrecy, and this is unacceptable.
EU-India FTA - IP chapter (draft 2013)
11-Mar-2013 KEI
Indian negotiators under pressure to give in to European Commission demands
11-Mar-2013 DNP+
Civil society and PLHIV networks across the world need to support us in this unequal and conclusive battle against the unfair demands of the European Commission on IP enforcement and investment standards.